Carolina Phase 1 Research (Wake M3) — Raleigh, North Carolina

Carolina Phase 1 Research (Wake M3) is a clinical research site located in Raleigh, North Carolina, United States 27612.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Carolina Phase 1 Research (Wake M3) has participated in 1 clinical trials.

Therapeutic areas: Alzheimer Disease.

Sponsors: Eli Lilly and Company.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Carolina Phase 1 Research (Wake M3)?

Carolina Phase 1 Research (Wake M3) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Carolina Phase 1 Research (Wake M3) conducted?

Carolina Phase 1 Research (Wake M3) has 1 clinical trials on record. Their work covers Alzheimer Disease.

Is Carolina Phase 1 Research (Wake M3) accredited by Crixeo Health?

Carolina Phase 1 Research (Wake M3) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Carolina Phase 1 Research (Wake M3)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.